Teduglutide: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Teduglutide. Educational only — not medical advice.
Labeled uses
GATTEX® is indicated for the treatment of adults and pediatric patients 1 year of age and older with Short Bowel Syndrome (SBS) who are dependent on parenteral support.
Source: FDA labeling via NIH DailyMed (set 66b69c1e…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.